TTNP logoTTNP
Titan Pharmaceuticals, Inc. (de)

32,990
Loading...
Loading...
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Titan Pharmaceuticals, Inc. (de)?
What is the 52-week high for Titan Pharmaceuticals, Inc. (de)?
What is the 52-week low for Titan Pharmaceuticals, Inc. (de)?
What is Titan Pharmaceuticals, Inc. (de) stock price today?
What was Titan Pharmaceuticals, Inc. (de) stock price yesterday?
What is the PE ratio of Titan Pharmaceuticals, Inc. (de)?
What is the Price-to-Book ratio of Titan Pharmaceuticals, Inc. (de)?
What is the 50-day moving average of Titan Pharmaceuticals, Inc. (de)?

Latest TTNP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.